INmune Bio Inc. (INMB)
NASDAQ: INMB
· Real-Time Price · USD
7.35
-0.67 (-8.35%)
At close: Jun 17, 2025, 3:10 PM
INmune Bio Revenue
INmune Bio reported an annual revenue of $14K, reflecting a -90.97% growth. For the quarter ending March 31, 2025, INmune Bio generated $50K in revenue.
Revenue (ttm)
$14K
Revenue Growth
-90.97%
Price / Sales Ratio
6652.85
Revenue / Employee
$1.08K
Employees
13
Market Cap
170.6M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|